Quick Summary
Inflitza 25mg Capsule
Last updated on 31 Mar 2026 | 09:30 AM (IST)
₹3214
MRP: ₹4017.19
(You Save ₹803.19)
4 CAPSULE(s) IN A STRIP
20% OFF
₹3214
MRP: ₹4,017.19
Inclusive of all taxes
20% Off
Dispatch: Today
Order In: 0h 0m 0s
0h 0m 0s
Order before timer ends to ensure your medicine is dispatched at...
Substitutes
Midostar 25mg Capsule
ZYDUS CADILA
₹ 607.50/capsule
24% cheaper
Mistaurin 25mg Capsule
GLENMARK PHARMA...
₹ 721.75/capsule
10% cheaper
Staurinz 25mg Capsule
DR REDDY'S LABO...
₹ 737.18/capsule
8% cheaper
Mstarin 25mg Capsule
BDR PHARMACEUTI...
₹ 759.39/capsule
5% cheaper


Introduction
Inflitza 25mg capsule contains the active substance midostaurin. It is an anti-cancer medicine belongs to the class of medications called tyrosine kinase inhibitors. It is combined with other chemotherapy medications to treat acute myeloid leukemia (AML) in adults with a defect in a gene called FLT3. Acute myeloid leukemia is a form of cancer that starts in certain WBC called myeloid cells in which the body overproduces these cells abnormally. The medicine is also used in adults to treat aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematological neoplasm (SM-AHN), or mast cell leukemia (MCL).
Do not take inflitza capsule if you are allergic to midostaurin or any other ingredients of this medicine. Inform your healthcare professional if you have any symptoms of an infection, heart disorder, lung problems, or problems with breathing. If you experience any of these symptoms, such as fever, sore throat, mouth ulcers, cough with or without mucous, chest pain, difficulty breathing, or swelling in the body parts after taking the medicine, immediately report it to your doctor.
This medicine is not recommended for children and adolescents below 18 years of age. Inform your physician if you are pregnant, breastfeeding, or planning for pregnancy before initiating the therapy. Inflitza 25mg capsule may reduce fertility in men and women; discuss this with your doctor before starting the therapy. This medicine's most common side effects are fever with reduced blood cell counts, nausea, vomiting, headache, musculoskeletal pain, increased blood glucose levels, and respiratory tract infection.
Uses
Inflitza capsule uses:
Acute myeloid leukemia (AML)
Aggressive systemic mastocytosis (ASM)
Systemic mastocytosis with associated hematological neoplasm (SM-AHN)
Mast cell leukemia (MCL)
How Inflitza 25mg Capsule Works
Inflitza 25mg capsule is a kinase inhibitor that potently inhibits multiple receptor tyrosine kinases. It blocks the action of the kinases in the abnormal cells that express FLT3 mutant genes and stops their division and growth.
Interaction of Inflitza 25mg Capsule with other drugs
Inform your healthcare provider about all the medicines you are taking, including prescription medications, over-the-counter medications, vaccinations, nutritional and vitamin supplements, and herbal products. Certain medications may interact with the effects of inflitza 25mg capsule and reduce its effectiveness by causing undesirable side effects.
Storage Conditions
- Store inflitza 25mg capsule at room temperature (25°C)
- keep the capsule away from the reach of children and pets.
- If you miss a dosage, take it as soon as you remember. If it is almost time for the next dose, skip the missing dose.
- Do not take a double dose to compensate for a missed dose.
How to take Inflitza 25mg Capsule
Your doctor will decide the dose and duration of the treatment based on your disease condition, severity, and other factors. Take the inflitza 25mg capsule as prescribed by your doctor. Do not open, break, crush, or chew the capsules. Swallow the capsule whole with a glass of water. Take the capsules with food at the same time each day.
Safety Advice for Inflitza 25mg Capsule
Breast Feeding
Breastfeeding is not recommended in patients taking inflitza 25mg capsule because the medicine passes into the breast milk in small amounts and may harm the baby.
Alcohol
It is unsafe to consume alcohol when taking inflitza 25mg capsule because it may cause alcohol-related problems, epilepsy, or liver problems.
Liver
Inflitza 25mg capsule should be cautiously administered in patients with severe liver diseases. Dose adjustments are necessary for severe liver failure. Inform your physician if you have liver problems before initiating the therapy.
Lungs
It is unknown whether inflitza 25mg capsule can be used in patients with lung disorders. Consult your doctor if you have any lung diseases before starting the treatment.
Driving
Driving vehicles or operating machinery after taking inflitza 25mg capsule is unsafe as you may develop dizziness and vertigo.
Pregnancy
Inflitza 25mg capsule is unsafe to administer in pregnant women because it may cause birth defects. Inform your physician if you are pregnant, suspect pregnancy, or planning to become pregnant. Using effective contraception during the treatment and for at least 4 months after your last dose is necessary.
Side Effects
Inflitza 25mg Capsule side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Inflitza 25mg side effects are
Serious
Heart failure
GI bleeding
Fever with decreased blood cell counts
Hypersensitivity reactions
Kidney problems
Pneumonia
Blood infection
Common:
Swelling in the lower limbs
Skin rash
Increased blood sugar levels
Abdominal pain
Constipation, diarrhea
Nausea, vomiting
Musculoskeletal pain
Headache
Bleeding from nose
Upper respiratory infection
Tiredness
Fever
Expert tips
-
Avoid grapefruit, grapefruit juice, and products containing St. John's wort during treatment.
-
Use effective birth control during treatment, for at least three weeks after the final dose for females, and fourteen weeks for males.
-
This medication may reduce fertility, so consult your doctor if you have any concerns.
-
Your doctor may recommend regular blood tests to monitor the effect of Piciclib 100 mg on your blood cells.
FAQs about Inflitza 25mg Capsule
Q1.
What are the cautions of inflitza 25mg capsule?
Tell your doctor immediately if you start to have swelling of your face, lower limbs or skin, fever, sore throat, mouth ulcers, cough with or without mucous, chest pain or discomfort, trouble breathing, shortness of breath, light-headedness, fainting, dizziness, blue discoloration of your lips, hands or feet.
Q2.
Can Inflitza 25mg capsule cause vomiting?
Yes, Inflitza 25mg capsule has a moderate emetic effect and can cause vomiting. Do not take an extra capsule if you have vomited after taking your first dose.
Q3.
Does inflitza 25mg capsule cause hair loss?
No, hair loss is not a side effect of inflitza 25mg capsule. Hair loss can happen due to the cancer itself. Consult your doctor if you have excessive hair loss.
Q4.
How will I be monitored during the treatment with inflitza 25mg capsule?
Your doctor will perform regular blood tests during treatment with rydapt in order to monitor the number of blood cells (white blood cells, red blood cells, and platelets) and electrolytes such as calcium, potassium, and magnesium in your body. Your heart and lung function will also be checked regularly.
Q5.
How long does it take inflitza 25mg capsule to work?
Inflitza 25mg capsule is a long-term treatment. Most people who benefit from this treatment will notice an improvement in the first 12 weeks of starting treatment.
Q6.
What will happen if I stop taking Inflitza 25mg capsule suddenly?
Stopping your treatment suddenly may cause your condition to become worse. Do not stop taking your medicine without consulting your doctor.
Fact Box
|
Molecule name: Midostaurin |
Therapeutic class: Antineoplastics |
|
Pharmacological class: Tyrosine kinase inhibitor |
Indications: 1. Acute myeloid leukemia (AML) 2. Aggressive systemic mastocytosis (ASM) 3. Systemic mastocytosis with associated hematological neoplasm (SM-AHN) 4. Mast cell leukemia (MCL) |
References
- Rydapt 25 mg soft capsules - Summary of Product Characteristics (SmPC) - (EMC). www.medicines.org.uk. [revised on 2022] [cited 2023 Apr 13]. Available from: https://www.medicines.org.uk/emc/product/9134/smpc
- Highlights Of Prescribing Information - Inflitza 25mg capsule, [revised on 2017] [cited 2023 Apr 13]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207997s000lbl.pdf
- Anton Wellstein, Giuseppe Giaccone, Michael B. Atkins, and Edward A. Sausville, Pathway-Targeted Therapies: Monoclonal Antibodies, Protein Kinase Inhibitors, and Various Small Molecules, Goodman & Gilman’s Pharmacological Basis of Therapeutics, 13th Edition, 2018, 1203-1236.
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that experts, accurate and trustworthy, review. The information and contents of this website are for informational purposes only. They are not intended to substitute for professional medical advice, diagnosis, or treatment. Please seek your doctor's advice and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details

Written By
Dr. Archana Gupta
BDS

Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 31 Mar 2026 | 09:30 AM (IST)

Want to know more?
Read Our Editorial Policy







